| Order book | ₹2,580 Cr |
|---|
BSE filing, NSE: LUMAXIND. Summary written from the filing by ALFA Finder's alert engine.
Lumax Industries Ltd: key numbers
- Share price
- ₹5,003.00
- Market cap
- ₹4,677 Cr
- Revenue (annual)
- ₹4,184 Cr
- Net profit (annual)
- ₹172.5 Cr
- P/E (TTM)
- 23.0×Sector 30.9×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 1.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lumax Industries Ltd
All →Lumax Industries Earnings Call Transcript: Key Takeaways
Lumax reported strong 33% revenue growth, raising full-year guidance despite temporary margin pressure from West Asia conflict-related supply chain and raw material costs.
- Call
- Guides 25% growth
Lumax Industries Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹1,342 Cr (+33% YoY), PAT ₹52 Cr (+46%). EBITDA margin 8.2% (-80 bps) on geopolitical supply-chain and input-cost pressure.
Lumax Industries Management Change
Lumax Industries extended the term of Company Secretary Mr. Raajesh Kumar Gupta by one year from January 2027. The extension follows his superannuation on December 31, 2026.
Lumax Industries Q2 FY27 Results: Net Profit ₹52 Cr, Up 46.1% YoY
Lumax Industries Ltd reported revenue from operations of ₹1,342 Cr (+33.0% YoY) and net profit of ₹52 Cr (+46.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹52 Cr · +46.1% YoY
Lumax Industries Other Announcement
Lumax Industries Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as required under SEBI (LODR) Regulations.
Lumax Industries Board Meeting Date
Lumax Industries will hold a board meeting on October 26, 2026, to approve its unaudited financial results for the quarter and half year ended September 30, 2026.
Other results update announcements
All →Narayana Hrudayalaya Results Update
Narayana Hrudayalaya reported Q2 FY27 consolidated revenue of Rs 28,440 Mn, up 73% YoY. PAT rose 16.6% to Rs 3,012 Mn, with the UK acquisition boosting revenue.
Corona Remedies Results Update
Corona Remedies released unaudited Q2 and H1 FY27 results highlights via press release. Revenue grew 22% year on year, with EBITDA and PAT also rising.
Acme Universal Safezone 9 Results Update
Acme Universal Safezone 9 reported H1FY27 revenue up 16.09% to ₹119.93 crore. EBITDA rose 54.62% and PAT turned to ₹7.02 crore profit.
Radiowalla Network Results Update
Radiowalla Network reported H1 FY27 revenue of ₹107.93 million, up 7% year-on-year. EBITDA rose to ₹8.16 million, with an 8% margin.
Artemis Medicare Services Results Update
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Advait Energy Transitions Results Update
Advait Energy reported Q2 FY27 consolidated revenue of ₹220.9 crore, up 40.8%, and PAT of ₹19.18 crore, up 88.5%. Its order book reached ₹1,574.8 crore.
- Order book
- ₹1,575 Cr